Ed Haislmaier
Ed Haislmaier is an expert in healthcare policy and markets at The Heritage Foundation, a conservative think tank. He focuses on the dynamics of healthcare pricing and regulation, offering insights into how government policies can affect the pharmaceutical market. Recently, he commented on the Trump administration's initiatives to lower drug prices, suggesting that the agreements with pharmaceutical companies might mitigate some of the negative impacts often associated with price controls.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 7.00 | 0.05% | +0% | 331,002,651 | 158,526 | $21,000,000 | 10,057$ |
| Totals | 1 | 331,002,651 | 158,526 | $21,000,000 | 10,057$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Ed Haislmaier is a senior research fellow in Heritage's DeVos Center for Human Flourishing.
7
United States:
Ed Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation, discussed the recent agreements involving companies trading lower prices for benefits.
5